Digital Health in Pharma Insights
How pharmaceutical manufacturers can benefit from moving to cloud today
For pharmaceuticals manufacturers, progressing digitalisation and moving to the cloud has been notoriously slow, and misperceptions of what moving to the cloud entails have been a significant factor in this lack of adoption. Read more
12 May 2022
3 ways virtual engagement will transform pharma in 2022
Mike Abbadessa, VP SME head of Medical Affairs at Within3, explores the benefits of pharma going virtual and whether the industry is prepared to do so. Read more
18 Feb 2022
App development is a golden opportunity - but pharma companies need to be wary
Liz Ashall-Payne, founding CEO of digital health consultancy ORCHA assesses the pharma's potential for digital apps and what the industry needs to bear in mind. Read more
7 Sep 2021
Who will prevail as the medical and tech worlds collide?
Joe Corrigan, head of Intelligent Healthcare, Cambridge Consultants part of Capgemini Invent, looks at how the medical and technology industries are colliding. Read more
18 Aug 2021
How pharma can improve acute and chronic patient care with digital health solutions
Brian Flatley, vice president of Consulting Services at S3 Connected Health looks at the digital health landscape and what its adoption means within pharma. Read more
25 Jun 2021
How digital platforms provide a bigger picture for patients in clinical trials
Paul O’Donohoe, Scientific Lead, eCOA and Mobile Health at Medidata explores how using digital platforms and remote solutions can give the broadest picture of patient response. Read more
13 Apr 2021
BCP partners with Finnish Biobanks to advance diagnostics and treatments
BC Platforms (BCP), announced its secured a multi-year contract to work with three Finnish Hospital District owned Biobanks (Clinical Biobanks) on improving access to, and automated management of phenotypic, genomic and clinical data. Read more
17 May 2022
ITN and New Scientist collaborate to distribute vaccinations programme
ITN Productions collaborates with New Scientist to host and distribute a news-style digital programme to their global audience of 5.2 million weekly readers, showcasing the technology and people at the forefront of advances in vaccine development. Read more
28 Apr 2022
iXensor receives investment from Rohto for digital health platform expansion
iXensor announced that Rohto Pharmaceutical Co., Ltd, a multinational pharmaceutical corporation, in Japan, has become the new strategic partner and shareholder, to expand its mobile health business globally and accelerate its PixoTech platform. Read more
28 Apr 2022
Sponsored Content
The challenges of sustainability
EPM sits down with Merck’s Jeffrey Whitford to find out about where the company is up to in terms of its sustainability initiatives. Read more
12 May 2022
Top three approaches for pharma communication
Pavel Klymenko, head of omnichannel excellence at Viseven, discusses his opinion on the best approaches to communication in pharma. Read more
6 May 2022
Research finds general public are positive about gene therapies
Polling conducted across six European countries, with over 6,000 respondents, finds high levels of excitement for gene therapy and medical innovation, particularly for the treatment of rare diseases. Read more
27 Apr 2022
Social media could be key to vaccinating older generation, study shows
Social media advertising could be a cost-effective of way of encouraging older people in deprived communities to get vaccinated, new research shows. Read more
19 Apr 2022
Perspective on Pharma: How powerful AI is turning intervention into prevention
We know disease exists, where it comes from and how it evolves - but we don’t yet know ahead of time when something changes to mark the start of a new disease, a new variant or just an increase in transmission. Read more
13 Apr 2022
Editor's desk: Reflections
In his last editor's desk, Reece Armstrong reflects on his time at the helm of European Pharmaceutical Manufacturer. Read more
5 Apr 2022
